Background Instability remains one of the most common indications for revision THA. However, little is known about the efficacy of surgery for and the complications associated with revision THA for patients with a chronically dislocated THA, which we define as a dislocation of more than 4 weeks.
Questions/purposes For patients with a chronically dislocated THA undergoing revision THA, we asked (1) What is the survivorship free from additional revision for these procedures? (2) What complications are associated with revision THA in this setting? (3) What are the clinical outcomes as measured by the Harris hip score in these procedures? Methods From 1998 to 2014, 1084 patients who underwent revision THA for instability were reviewed and 33 patients (33 hips) were identified who had a hip that had been dislocated for more than 4 weeks. Median time dislocated was 4 months (range, 1-120 months), and the mean distance of the femoral head above hip center at presentation was 45 mm. Mean patient age was 67 6 17 years, and 79% of patients (26 of 33) were women. During the period in question, we used four approaches: Treatment with acetabular component revision in 18 of 33 patients (55%), head and liner exchange in nine patients (27%), both-component revision in five patients (15%), and isolated femoral component revision in one patient (3%). A constrained liner was used in 17 patients (52%), including six of the patients treated with acetabular component revision, and three of those who had both-component revisions. During the period in question, our general indications were hip pain and/or unacceptable function with the chronically dislocated prosthesis. Our sample size was too small to evaluate the association of the procedure choice on survivorship or complication risk. We used Kaplan-Meier survivorship analysis to estimate survivorship free from complication, reoperation, or revision. Mean followup was 4.4 years (range, 2-10 years). Results Survivorship free from any revision, complication, or reoperation was 61% at 5 years (95% CI, 43-82). Survivorship free from revision was 83% at 5 years (95% One of the authors certifies that he (DJB) has received or may receive payments or benefits, during the study period, an amount more than USD 1,000,001, from DePuy (Warsaw, IN, USA). One of the authors certifies that he (DGL) has received or may receive payments or benefits, during the study period, an amount more than USD 1,000,001, from Zimmer-Biomet (Warsaw, IN, USA). One of the authors certifies that he (RTT) has received or may receive payments or benefits, during the study period, an amount more than USD 1,000,001, from DePuy (Warsaw, IN, USA). One of the authors certifies that he (RJS) has received or may receive payments or benefits, during the study period, an amount of USD 100,001 to USD 1,000,000, from Zimmer-Biomet (Warsaw, IN, USA). Clinical Orthopaedics and Related Research® neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA approval status, of any drug or device before clinical use. Each author certifies that his institution approved the human protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research. CI, 67-98). Etiology for revision was aseptic loosening in three of 33 hips (9%), recurrent dislocation in two hips (6%), and deep periprosthetic joint infection in two hips (6%). Five complications (15%) did not result in a reoperation, including one dislocation and one incomplete peroneal nerve palsy in a patient after an anterolateral approach. The Harris hip score improved from mean 50 6 17 preoperatively to mean 80 6 11 at 5 years. Conclusions Chronically dislocated THAs can be successfully managed with revision THA. We recommend close evaluation of the components for aseptic loosening, performing revision surgery only on patients with pain and poor function, and thoroughly counseling patients that survivorship is modest and complications are common. Level of Evidence Level IV, therapeutic study.
Introduction
Dislocation remains one of the most common complications after primary THA, reported in up to 5% of patients who undergo the procedure [2, 3, 5-10, 12, 13, 18-21] . Instability after revision THA is also reported to complicate up to 9% of patients [11] , and the cumulative risk of redislocation after revision THA for instability approaches 35% at 15 years [16] . In most patients, an isolated THA dislocation can be treated with a closed reduction [24] . However, a dislocated THA may remain dislocated in certain circumstances: if the patient is too infirm to undergo further procedures, at the surgeon's discretion if a referral is necessary for the anticipated procedure to correct the instability, and, rarely, from neglect.
Treatment of chronically dislocated hips is difficult, and we are not aware of any published data that can guide surgical management. After our own experience with several challenging chronically dislocated THAs, we sought to analyze our institution's overall experience with this clinical problem.
We asked the following questions for patients with a chronically dislocated THA undergoing revision THA: (1) What is the survivorship free from additional revision for these procedures? (2) What complications are associated with revision THA in this setting? (3) What are the clinical outcomes as measured by the Harris hip score in these procedures?
Patients and Methods
We obtained institutional review board approval before we initiated this retrospective study. Using our longitudinally maintained total joint registry, we identified 1084 revision THAs performed due to instability at our tertiary referral institution between 1998 and 2014; this cohort included contemporary THA implants with at least 2 years' followup. A radiographic and clinical review of each revision identified 33 patients (33 hips) who were dislocated at the time of the revision THA and who had radiographic documentation of the dislocation for more than 4 weeks prior to the revision THA (Fig. 1 ). Of these patients, 12 had chronic dislocation after primary THA and 21 had chronic dislocation after a revision THA. The mean patient age was 67 years (6 16.9 years). Mean total time dislocated was 4 . The mean followup after revision was 4.4 years (range, 2-10 years). There were no patients lost to followup before 2 years. Patients were followed in the registry until death or revision of any component. One patient had surgery in 1998 and was lost after 2-year followup. Attempts to contact the patient were unsuccessful. Patients were followed with an office visit, outcome scores, and radiographs at 6 weeks, 3 months, 1 year, 2 years, 5 years, and every 5 years thereafter in line with our registry standard. Harris hip scores were collected at each followup visit.
Patients were included in the study if they met the following criteria: the immediate preoperative films revealed a dislocated THA, a chart review confirmed that the hip was dislocated on approach in the operating room, and the dislocation occurred more than 4 weeks prior with no interval reduction. Patients were excluded if testing prior to revision revealed a periprosthetic joint infection (PJI). Radiographic data were collected from the preoperative films obtained in the week before the revision THA.
Description of Experiment, Treatment, or Surgery
Over this period, 12 orthopaedic surgeons performed revision THAs at one institution. Before revision for the chronic dislocation, all patients were tested for PJI and each hip was deemed aseptic. At the time of the revision arthroplasty, the surgeons used a variety of surgical approaches for the 33 procedures, including 25 anterolateral (76%), five posterolateral (15%), two extended trochanteric osteotomies (6%), and one transtrochanteric (3%) approach. The surgical approach was chosen at the surgeon's discretion. We reviewed clinical documentation to understand the reason for component revision.
During the period in question, we used four revision techniques to manage this problem. We used acetabular component revision alone in 18 of 33 patients (55%), head and liner exchange in nine patients (27%), both-component revision in five of 33 patients (15%), and isolated femoral component revision in one patient (3%; Table 1 ). The most common reason for revision of the acetabular component was aseptic loosening (18 of 23 patients, 78%), and the most common reason for revision of the femoral component was inability to reduce the hip (four of six patients, 66%; Table 2 ). A constrained liner was used in 17 of 33 patients (52%), including six of the patients treated with acetabular component revision, and three of those who had bothcomponent revisions. A dual-mobility construct was used in three hips (9%; Table 1 ). Femoral head size in the nonconstrained and nondual mobility hips were 32 mm or less in eight hips (62%) and 36 mm or greater in five hips (32%). During the period in question, our general indications for revision in this population were pain and poor function associated with the chronically dislocated THA. The type of revision surgery the patient underwent was individualized to the etiology of each patient's instability. In most patients, the acetabular, femoral, or both components were loose and thus revised. In patients with well-fixed and appropriately positioned implants, we attempted head and liner exchange as the primary means of achieving stability. Our sample size was too small to evaluate any association between procedure choice and survivorship or complication risk.
We specifically reviewed each patient's medical records to obtain demographic and surgical data, complications, reoperations, revisions, and clinical outcomes. Independent observers not involved with patient care (TSB, RJM) reviewed the films for direction of the dislocation, distance from the native hip center to the center of the femoral head, radiographic signs of aseptic loosening, and for the characteristic signs of pelvic discontinuity [4] . On preoperative radiographic review, the dislocation was posterior in 16 hips (50%). The acetabular component was deemed loose by component migration compared with prior films, hardware fracture, or > 1 mm radiolucent line in multiple zones in 18 hips (52%). All femoral components 
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Inability to reduce hip 4 (66%) Malposition 1 (17%) Lack of modularity 1 (17%) were well-fixed on radiographic review. Two hips had radiographic evidence of pelvic discontinuity. We made every attempt to mitigate bias in this study by having the analyses performed by physicians not involved with patient care. We also made every attempt to locate each patient who underwent a revision THA for this diagnosis by examining the immediate preoperative radiographs of every patient undergoing revision THA during this period in addition to reviewing the registry for preoperative diagnosis codes.
Statistical Analysis, Study Size
We reported the descriptive statistics as the number (percentage) for discrete variables and as mean (SD) or median (range) as appropriate. We assessed the following survival outcomes: freedom from any component revision (defined as removal of implant in contact with host bone), and freedom from first surgical complication (dislocation, wound healing issue, surgical site infection), reoperation, or revision for any reason. We estimated the survival free of each outcome of interest using the Kaplan-Meier method [17] . All tests were two-tailed and at an alpha level of 0.05 for statistical significance. All analyses were done using SAS version 9.4 (SAS Institute Inc, Cary, NC, USA).
Results
The estimated revision-free survivorship was 87% at 2 years (95% CI, 76-99) and 83% at 5 years' followup (95% CI, 67-98; Fig. 2) . At final followup, seven hips had undergone re-revision (21%). In three hips (9%), the etiology for revision was aseptic loosening, recurrent dislocation in two hips (6%), and deep PJI in two hips (6%). Survivorship free from revision, complications, or reoperation was 66% at 2 years (95% CI, 51-84) and 61% at 5 years' followup (95% CI, 43-82; Fig. 3 ). There were an insufficient number of events to analyze for factors associated with dislocation, survivorship, and complications.
Instability was the most common complication after these revisions, occurring in five of 33 hips (15%). Transient palsy of the peroneal division of the sciatic nerve was documented in one patient (3%). Reoperation without component revision occurred in two hips (6%), one for periprosthetic femur fracture and in another for heterotopic ossification.
The mean Harris hip score improved from 50 6 17 preoperatively to 80 6 11 at 5 years' followup.
Discussion
Revision THA for chronically dislocated THA is uncommon and challenging. We hoped to add to the understanding of the treatment and prognosis of this entity, which to our knowledge has only been described previously in a single case report [23] . Among the challenges faced is that correction of the dislocation may involve the removal of a well-fixed implant. In our series, revision for chronic THA dislocation had a modest overall success rate and recurrent instability was common.
Our study is limited by the small number of patients, which hampered our ability to analyze outcome-associated factors. The small number of patients may also mean there are presentations of chronically dislocated THAs that were missed by our study. The method of identifying patients also failed to capture the number of patients with a chronic THA dislocation who did not undergo revision THA. The rarity of the underlying problem also helped contribute to the cohort heterogeneity in terms of the implants used and surgical treatment strategies available over the 15-year period of case collection. The retrospective study design introduced selection bias, as many different surgeons over the study period might have offered different treatments for the same problem. Over the long study period there have been some patients lost to followup in our institution's registry, another weakness of the retrospective design.
Survivorship free from complication, reoperation, or rerevision was 61% at 5 years' followup in our series. In comparison, Abdel et al. [1] reported a 96% survivorship free from re-revision at 10 years' followup in 519 aseptic THA revisions. Revision for periprosthetic femur fracture has a reported 79% survivorship free from revision at 10 years [22] . Revision for instability and failure of a constrained liner has a 10-year survivorship free from revision of 24% [15] . Our study was too small to identify any risk factors associated with re-dislocation or repeat revision. Future, larger studies should help determine whether the use of a constrained liner was associated with a higher (or lower) revision rate.
Not surprisingly, the most common complication after revision for chronic dislocation of a THA was recurrent instability, which occurred in five of 33 patients (15%); 40% of these patients underwent reoperation. Neurologic injury was uncommon despite potential concerns with lengthening of a chronically shortened extremity. Harris hip scores improved after revision THA for chronic dislocation and were comparable to other revision THA series at 5 years [1, 15, 22] , presuming recurrent instability and infection were avoided.
Our study found only 3% of revision THAs performed due to instability at our tertiary referral institution fit our criteria of a chronically dislocated THA (> 4 weeks), which might explain the paucity of prior clinical evidence. We were surprised to find that an osteotomy was performed in only a small number of patients (three of 33). We also did not anticipate that such a small minority of patients -five of 33 (15%) -would undergo revision of both components for stability at the time of revision THA. The most commonly associated finding at surgery was a loose acetabular component, which helped contribute to isolated acetabular revision in many patients (18 of 33 [55%]). We believe that in most patients, the loose acetabular component is likely the underlying etiology for the initial instability, and surgeons should pay close attention to the component fixation in these hips. While revision of any loose or malpositioned component is necessary, surgeons should also be prepared for the occasional need to revise a well-fixed femoral component for safe access to the joint and treatment of the chronic dislocation, especially if the femoral head cannot be returned to the level of the native acetabulum without excessive traction.
We found that treatment for chronic dislocation after THA (from 1 month to 10 years) has modest survivorship free from revision and major complications are common. Extended trochanteric osteotomy and femoral component revision were rarely used in our series. The decisions regarding surgical approach and implant revision or retention should be individualized for each patient. We found aseptic loosening of the acetabular component to be a major factor in most patients, and surgeons should be prepared to revise the acetabular component. Given their performance in revision THA due to instability, an extensively porouscoated shell that allows dual-mobility articulation is currently the preference of all authors [14] . Patients and surgeons should be aware of the modest survivorship and risk of complications that can be expected for this diagnosis given the results of our series. Larger multicenter cohorts are necessary to add additional insight into the factors that might lead to improved survivorship.
